Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback